Huntington’s Disease Clinical Trials Corner: March 2024
Carlos Estevez‐Fraga, Sarah J. Tabrizi, Edward J. Wild
Abstract
In this edition of the Huntington's Disease Clinical Trials Update, we expand on the ongoing program from VICO Therapeutics and on the recently terminated VIBRANT-HD clinical trials. We also discuss updates from uniQure's AMT-130 program and PTC therapeutics' trial of PTC518 and list all currently registered and ongoing clinical trials in Huntington's disease.
Topics & Concepts
Clinical trialHuntington's diseaseDiseaseMedicineInternal medicineGenetic Neurodegenerative DiseasesMitochondrial Function and PathologyNeurological disorders and treatments